Pα+ Psychedelic Bulletin #216: Australia’s Psychedelics-for-Veterans Funding; New Mexico Targets 2026 Medical Psilocybin Launch; Radial Scores $50M; Otsuka’s “Novel Serotonergic Agonists”; Psilocybin Accelerates Brain Tumour Growth in Mice; Texas’ $50M Ibogaine Study Consortium

Last week, the Australian Department of Veterans’ Affairs (DVA) shared a clinical briefing webinar it hosted for Authorised Prescribers to discuss its reimbursement program for psychedelic-assisted psychotherapy (PAP). As we covered in Bulletin 213, Australia’s DVA has become the first body of its kind in the world to agree to fund PAP after the Repatriation Commission and…

Source